The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Circulating Biomarkers of Distinct Pathophysiological Pathways in Heart Failure with Preserved vs. Reduced Left Ventricular Ejection Fraction
Open accessAbstract
Aims: The aim of this study was to evaluate whether biomarkers reflecting pathophysiological pathways are different between heart failure with preserved (HFpEF) and reduced ejection fraction (HFrEF) and whether the prognostic value of biomarkers is different in HFpEF vs. HFrEF. Methods and results: A total of 458 HFrEF (LVEF ≤40%) and 112 HFpEF (LVEF ≥50%) patients aged ≥60 years with NYHA class ≥II from TIME-CHF were included. Endpoints are 18-month overall and HF hospitalization-free survival. After correction for baseline characteristics that differed between the HF types, i.e. age, gender, body mass index, systolic blood pressure, cause of HF, and AF, HFpEF patients exhibited higher soluble interleukin 1 receptor-like 1 [ST2; 37.6 (28.5–54.7) vs. 35.7 (25.6–52.2), P = 0.02], high sensitivity C-reactive protein (hsCRP; 8.54 (3.39–25.86) vs. 6.66 (2.42–15.39), P = 0.01), and cystatin-C [1.94 (1.57–2.37) vs. 1.75 (1.39–2.12), P = 0.01]. In contrast, HFrEF patients exhibited higher NT-proBNP [2142 (1473–4294) vs. 4202 (2239–7411), P < 0.001], high sensitivity troponin T [hsTnT; 27.7 (16.8–48.0) vs. 32.4 (19.2–59.0), P = 0.03], and haemoglobin [124 (110–135) vs. 134 (122–145), P < 0.001]. In addition to these clinical characteristics, NT-proBNP, haemoglobin, cystatin-C, hsTnT, and ST2 improved the area under the curve from 0.86 (0.82–0.89) to 0.91 (0.87–0.94; P < 0.001) for discriminating HFpEF from HFrEF. There were no significant interactions between HFpEF and HFrEF when considering the prognostic value of the investigated biomarkers (P > 0.10 for both endpoints), except for cystatin-C which had less prognostic impact in HFpEF (P < 0.01). Conclusion: Biomarker levels suggest a different amount of activation of several pathophysiological pathways between HFpEF and HFrEF. No important differences in the prognostic value of biomarkers in HFpEF vs. HFrEF were found except for cystatin-C, and for NT-proBNP in the NT-proBNP-guided study arm only, both of which had less prognostic value in HFpEF. Trial registration: ISRCTN43596477
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Dickstein, K., Authors/Task Force Members, Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.005 · Cited by 3,512
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644
de Lemos, J. A., Drazner, M. H., Omland, T., Ayers, C. R., Khera, A., Rohatgi, A., Hashim, I., Berry, J. D., Das, S. R., Morrow, D. A., et al. (2010) · JAMA · doi:10.1001/jama.2010.1768 · Cited by 1,102
Aliskiren, ALTITUDE, and the Implications for ATMOSPHERE
McMurray, J. J. V., Abraham, W. T., Dickstein, K., Køber, L., Massie, B. M., & Krum, H. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs033 · Cited by 1,096
Daniels, L. B., & Maisel, A. S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.021 · Cited by 952
Pfisterer, M., Buser, P., Rickli, H., Gutmann, M., Erne, P., Rickenbacher, P., Vuillomenet, A., Jeker, U., Dubach, P., Beer, H., et al. (2009) · JAMA · doi:10.1001/jama.2009.2 · Cited by 652
Self-citationTribouilloy, C., Rusinaru, D., Mahjoub, H., Souliere, V., Levy, F., Peltier, M., Slama, M., & Massy, Z. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehm554 · Cited by 441
van Veldhuisen, D. J., Linssen, G. C. M., Jaarsma, T., van Gilst, W. H., Hoes, A. W., Tijssen, J. G. P., Paulus, W. J., Voors, A. A., & Hillege, H. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.044 · Cited by 414
Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure
Rehman, S. U., Mueller, T., & Januzzi, J. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.042 · Cited by 386
Troughton, R. W., Frampton, C. M., Brunner-La Rocca, H.-P., Pfisterer, M., Eurlings, L. W. M., Erntell, H., Persson, H., O'Connor, C. M., Moertl, D., Karlstrom, P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu090 · Cited by 275
Self-citationHeart Failure With Normal Left Ventricular Ejection Fraction
Maeder, M. T., & Kaye, D. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.007 · Cited by 270
Self-citationEmerging Biomarkers in Heart Failure
van Kimmenade, R. R. J., & Januzzi, J. L. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.165720 · Cited by 257
Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population
McDonagh, T. A. (2001) · Heart · doi:10.1136/heart.86.1.21 · Cited by 255
Anand, I. S., Rector, T. S., Cleland, J. G., Kuskowski, M., McKelvie, R. S., Persson, H., McMurray, J. J., Zile, M. R., Komajda, M., Massie, B. M., et al. (2011) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.962654 · Cited by 249
Santhanakrishnan, R., Chong, J. P. C., Ng, T. P., Ling, L. H., Sim, D., Toh G. Leong, K., Shuan D. Yeo, P., Ong, H. Y., Jaufeerally, F., Wong, R., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs130 · Cited by 217
Manzano-Fernández, S., Mueller, T., Pascual-Figal, D., Truong, Q. A., & Januzzi, J. L. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.09.011 · Cited by 209
McAlister, F. A., Ezekowitz, J., Tarantini, L., Squire, I., Komajda, M., Bayes-Genis, A., Gotsman, I., Whalley, G., Earle, N., Poppe, K. K., et al. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.966242 · Cited by 202
Tumor Necrosis Factor-α and Mortality in Heart Failure: A Community Study
Dunlay, S. M., Weston, S. A., Redfield, M. M., Killian, J. M., & Roger, V. L. (2008) · Circulation · doi:10.1161/circulationaha.107.759191 · Cited by 186
The Novel Biomarker Growth Differentiation Factor 15 in Heart Failure with Normal Ejection Fraction
Stahrenberg, R., Edelmann, F., Mende, M., Kockskämper, A., Düngen, H.-D., Lüers, C., Binder, L., Herrmann-Lingen, C., Gelbrich, G., Hasenfuß, G., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq151 · Cited by 161
Biomarkers of Heart Failure with Normal Ejection Fraction: A Systematic Review
Cheng, J. M., Akkerhuis, K. M., Battes, L. C., van Vark, L. C., Hillege, H. L., Paulus, W. J., Boersma, E. H., & Kardys, I. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft106 · Cited by 126
Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction
Bishu, K. G., Deswal, A. M., Chen, H. H., LeWinter, M. M., Lewis, G. D., Semigran, M. J., Borlaug, B. A., McNulty, S. E., Hernandez, A. F., Braunwald, E., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.08.014 · Cited by 123
Rocca, H. B., Buser, P. T., Schindler, R., Bernheim, A., Rickenbacher, P. R., & Pfisterer, M. E. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.10.022 · Cited by 109
Self-citationGrewal, J., McKelvie, R. S., Persson, H., Tait, P., Carlsson, J., Swedberg, K. B., Östergren, J., & Lonn, E. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.04.048 · Cited by 107
Krum, H., Elsik, M., Schneider, H. G., Ptaszynska, A., Black, M. J., Carson, P. E., Michel Komajda, N., Massie, B. M., McKelvie, R. S., McMurray, J. J. V., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.960716 · Cited by 104
Izumiya, Y., Hanatani, S., Kimura, Y., Takashio, S., Yamamoto, E., Kusaka, H., Tokitsu, T., Rokutanda, T., Araki, S., Tsujita, K., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.12.010 · Cited by 79
Prognostic Value of Cystatin C on Admission in Heart Failure With Preserved Ejection Fraction
Carrasco-Sánchez, F. J., Galisteo‐Almeda, L., Páez‐Rubio, M. I., Martínez‐Marcos, F. J., Camacho-Vázquez, C., Ruíz-Frutos, C., & Llave, E. P.-D. L. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.07.248 · Cited by 76
Maeder, M. T., Rickenbacher, P. R., Rickli, H., Abbühl, H., Gutmann, M., Erné, P., Vuilliomenet, A., Peter, M., Pfisterer, M. E., Rocca, H. B., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft076 · Cited by 75
Self-citationParekh, N., & Maisel, A. S. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328320d82a · Cited by 74
Wisniacki, N., Taylor, W., Lye, M., & Wilding, J. P. H. (2004) · Heart · doi:10.1136/hrt.2003.029652 · Cited by 67
Quiroz, R., Doros, G. D., Shaw, P., Liang, C., Gauthier, D. F., & Sam, F. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.11.014 · Cited by 65
Predictive value of high sensitivity CRP in patients with diastolic heart failure
Michowitz, Y., Arbel, Y., Wexler, D., Sheps, D. S., Rogowski, O., Shapira, I., Berliner, S. A., Keren, G., George, J., & Roth, A. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.02.037 · Cited by 65
Inflammatory pathways in patients with heart failure and preserved ejection fraction
Niethammer, M., Sieber, M., von Haehling, S., Anker, S. D., Münzel, T. F., Horstick, G., & Genth‐Zotz, S. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.05.061 · Cited by 54
Latado, A. L., Passos, L. C. S., Darzé, E. S., & Lopes, A. A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.07.045 · Cited by 36
Casado, J., Montero-Pérez-Barquero, M., Formiga, F., Carrera, M., Urrútia, A., Arévalo‐Lorido, J. C., & Pérez‐Calvo, J. I. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.06.003 · Cited by 32
de Denus, S., Lavoie, J., Ducharme, A., O’Meara, E., Racine, N., Sirois, M. G., Neagoe, P., Zhu, L., Rouleau, J. L., & White, M. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.09.007 · Cited by 28
Perna, E. R., Aspromonte, N., Canella, J. P. C., Tano, G. D., Macin, S. M., Feola, M., Coronel, M. L., Milani, L., Parras, J. I., Milli, M., et al. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.10.008 · Cited by 28
Novel biomarkers for heart failure
Iqbal, N., Alim, K. S., Aramin, H., Iqbal, F., Green, E., Higginbotham, E., & Maisel, A. S. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.832476 · Cited by 26
van Empel, V. P. M., & Kaye, D. M. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.05.006 · Cited by 16
Cited by
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap
Shah, S. J., Kitzman, D. W., Borlaug, B. A., van Heerebeek, L., Zile, M. R., Kass, D. A., & Paulus, W. J. (2016) · Circulation · doi:10.1161/circulationaha.116.021884 · Cited by 1,003
Heart Failure With Preserved Ejection Fraction In Perspective
Pfeffer, M. A., Shah, A. M., & Borlaug, B. A. (2019) · Circulation Research · doi:10.1161/circresaha.119.313572 · Cited by 837
Heart Failure With Preserved Ejection Fraction
Borlaug, B. A., Sharma, K., Shah, S. J., & Ho, J. E. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.01.049 · Cited by 742
Evaluation and management of heart failure with preserved ejection fraction
Borlaug, B. A. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0363-2 · Cited by 675
Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
Hanna, A., & Frangogiannis, N. G. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07071-0 · Cited by 418
Metadata
- Authors
- Sanders-van Wijk, S., van Empel, V., Davarzani, N., Maeder, M. T., Handschin, R., Pfisterer, M. E., Brunner-La Rocca, H. P., & for the TIME-CHF investigators
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-01
- Volume
- 17
- Issue
- 10
- Pages
- 1006-1014
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W1900173585
- Cited by
- 258
- References
- 40
- FWCI
- 16.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.